Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of <i>Helicobacter pylori</i> Eradication?

Gut Liver · 2021 · PMC8593510 · PMID 33850058

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

We performed an RCT to explore whether a clinically significant difference was apparent between VPZ-based and PPI-based triple therapies for CAM-susceptible H. pylori eradication.

also in 830 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.